Conceptio › Archive › Europe PMC
Europe PMCopen access

FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook

Moriyama H et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
fda
Antisense oligonucleotide, Duchenne muscular dystrophy, Dystrophin, Fda, Exon Skipping, Eteplirsen
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 314819
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.